STAMBPL1 and carcinoma: Carcinomas often display heterogeneity in epithelial and mesenchymal markers in various combinations.16 This necessitated us to interrogate whether the clinical patient data on STAMBPL1 translate into the genomic features of carcinoma cell line models.